The rs13064411 polymorphism in the WDR52 gene, associated with PCSK9 levels, modifies statin-induced changes in serum total and LDL cholesterol levels

2015

Pharmacogenetics and Genomics , Volume 25 - Issue 3 p. 134- 142

Additional Metadata
Keywords	cholesterol, HMG-CoA reductase inhibitors, PCSK9, pharmacogenetics, rs13064411
Persistent URL	doi.org/10.1097/FPC.0000000000000120, hdl.handle.net/1765/88888
Journal	Pharmacogenetics and Genomics
Organisation	Department of Internal Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	de Keyser, C.E, Becker, M.L, Hofman, A, Lous, J.J, Uitterlinden, A.G, Visser, L.E, & Stricker, B.H.Ch. (2015). The rs13064411 polymorphism in the WDR52 gene, associated with PCSK9 levels, modifies statin-induced changes in serum total and LDL cholesterol levels. Pharmacogenetics and Genomics, 25(3), 134–142. doi:10.1097/FPC.0000000000000120

Publication